Introduction
Primary hyperparathyroidism (PHPT) is the third most common endocrine disorder after diabetes and hyperthyroidism. 1 Involvement of one parathyroid gland is the most common presentation of PHPT occurring in 80%-85% of patients. 1, 2 Most patients are either asymptomatic or have vague nonspecific symptoms. The disease is usually found on routine serum calcium measurements. However, approximately one-third of the patients submit your manuscript | www.dovepress.com Dovepress Dovepress 2 Gayed et al usually become symptomatic over a 15-year period. 3 Operative resection of the parathyroid adenoma is the only curative treatment in PHPT. Parathyroidectomy has evolved significantly over the past 3 decades. A major 4 glands neck exploration and intraoperative palpation in attempt to identify and resect the parathyroid adenoma have changed to minimally invasive procedure with significant decrease in the size of the neck scar and postoperative morbidity. [4] [5] [6] This major evolution of parathyroidectomy is the result of significant advancement in parathyroid imaging. Multiple imaging modalities are presently available to help preoperative precise localization of parathyroid adenomas including radionuclide imaging, ultrasound, [7] [8] [9] four dimensional computerized tomography (4D CT), 10 and/or magnetic resonance imaging (MRI). 11 Intraoperative localization can also be enhanced with intraoperative ultrasound, intraoperative injection of Tc-99m sestamibi for gamma probe localization, or intraoperative MRI. [12] [13] [14] Resection of the pathologic parathyroid adenoma is confirmed with intraoperative reduction of parathyroid hormone (PTH) level of ≥50% of the baseline level preoperatively. 15, 16 Radionuclide imaging has also improved significantly over the past 2 decades. It started with the dual-tracers sequential subtraction parathyroid scintigraphy which was difficult to perform requiring patient compliance with no motion throughout the study. 17 This was followed by the more robust single tracer dual-phase protocols using Tc-99m sestamibi 17, 18 or Tc-99m tetrofosmine 19 with better accuracy of parathyroid adenoma or hyperplasia detection. The addition of single-photon emission computerized tomography (SPECT) and subsequently SPECT/CT has improved the detection rate and localization of the abnormal parathyroid gland significantly. [20] [21] [22] [23] Simultaneous dual tracer imaging with a thyroid specific tracer like I-123 with the Tc-99m sestamibi is thought to decrease imaging time and decrease false positive studies in patients with coexisting thyroid abnormalities. 23 Most institutions will perform at least 2 imaging modalities to confirm the presence and location of an abnormal parathyroid gland. This is usually a combination of ultrasound and parathyroid scan. 24, 25 Additional imaging modalities as MRI or 4D CT may be thought for discordant or inconclusive results between US and parathyroid scans. 10 Our study evaluated the accuracy and outcomes from a standardized simple method of interpretation and reporting of Tc-99m sestamibi dual-phase scan with SPECT/CT as the imaging modality for the diagnosis and localization of parathyroid adenoma in patients with PHPT. After a long experience with interpretation of SPECT and SPECT/CT as part of parathyroid scans, we have developed a systematic approach to the interpretation of parathyroid scans, which we believe can contribute to higher accuracy in identifying the abnormal parathyroid gland. Additionally, our method of reporting the location of the parathyroid adenoma facilitates clear and simple standard mean of communication with the surgeons of the location of the abnormal parathyroid gland with favorable surgical outcomes. Our method of interpretation and reporting of Tc-99m sestamibi dual-phase scan with SPECT/CT can help other imagers and labs to improve on their accuracy for diagnosis and localization of parathyroid adenomas.
Materials and methods
After obtaining the UT Health-Memorial Hermann Hospital Institutional Review Board approval to conduct this study. Since our study is a retrospective study obtaining a consent form from the patients was waived by the IRB. We retrospectively included all consecutive patients who underwent Tc-99m sestamibi parathyroid scans (SPS) with SPECT/CT followed by parathyroidectomy between April 2012 and April 2014. Data collected included patients' demographics, serum calcium levels, preoperative and intraoperative PTH levels, parathyroid scan findings from reports, interval between parathyroid scan and parathyroidectomy, and surgical and pathological findings.
Systematic interpretations of parathyroid scans
After a long experience and open communication with our experienced surgeons performing the parathyroidectomies, our two experienced nuclear medicine physicians developed a systematic approach to the interpretation of parathyroid scans with SPECT/CT. The steps for our systematic interpretations are as follows:
• We conduct an initial review of 20 minutes and 2-3 hours delayed planer images of the neck and chest obtained in the anterior and bilateral anterior oblique positions. Any foci of increased tracer uptake regardless of their intensity are noted for further evaluation on the SPECT/CT images. Faint foci of uptake may occasionally be seen on oblique images of the neck rather than on the anterior planar image. Focal increased uptake seen on early images may or may not show retention on delayed planer images in parathyroid adenomas but will direct the readers' attention to the side of possible adenoma. We also look for possible ectopic parathyroid adenomas between the thyroid gland and floor of the mouth or submandibular glands as well as between the heart and the thyroid gland. • Subsequently, we review the coronal SPECT/CT slices to confirm the presence of focal uptake and its laterality and Parathyroid scan interpretation relative location to the thyroid lobes in a cranio-caudal level. It is better to start from anterior slices of the thyroid while observing for any focal uptake below the thyroid lobes or asymmetric elongation of one thyroid lobe inferiorly which are the typical appearances of an inferior parathyroid adenomas. Continuous slow scrolling through the thyroid gland will help to differentiate thyroid versus parathyroid adenomas. A superior parathyroid adenoma will usually appear as focal tracer concentration in the immediate few slices posterior to the thyroid gland at different cranio-caudal levels compared with the thyroid gland since most of the superior parathyroid glands tend to grow inferiorly in the tracheoesophageal groove. 
Parathyroid scan protocol
Patients were injected intravenously with 20-25 mCi of Tc-99m sestamibi. Using low-energy high-resolution collimator and 10% window around the Technetium-99m photopeak (140 kev), anterior and left and right anterior oblique planar images were obtained at 20 minutes for 7 minutes and at 2-3 hours postinjection for 10 minutes each. These images were acquired into a 128×128 matrix with 1.6 zoom. SPECT/CT images were obtained at 45-60 minutes postinjection using the following parameters: 360° arch, 3°/step, 120 images, average time per stop is 27 seconds±1-3 seconds as needed according to patient size and activity. The CT part is acquired simultaneously with the SPECT images using axial mode (5 mm interval), 140 kV, 2.5 mA, full rotation. The associated reconstruction parameters are 512×512 matrix, 1 mm pixel size, bone filter, and extended field of view.
Statistical analysis
Descriptive statistics was used to analyze the data collected using mean, median, and percentages. Correlation between image findings and postoperative pathological findings as the gold standard was also expressed as percentages of all the patients included in the study.
Results
The total study population consisted of 53 patients, 9 males and 44 females with an average age of 58.3±14.0 years. The average preoperative serum calcium and PTH levels were 10.5±1.1 mg/dL and 165.4±79.8 pg/mL, respectively. The mean and median interval between the scan and operative resection was 104 and 50 days, respectively. The correlation between SPS findings and surgical findings are summarized in Table 1 . SPS interpretation correlated perfectly with surgical findings in 48/53 patients (90.6%). In three patients (5.7%), SPS interpretation was on the correct side of the neck in correlation with surgical findings but not the exact location; that is, two patients SPS indicated a right superior parathyroid adenoma but intraoperatively they were inferior parathyroid adenoma and in the third patient, SPS indicated a left superior parathyroid adenoma, and intraoperatively it was left inferior adenoma. The correct location of the parathyroid adenoma was missed by SPS in two patients (3.7%). Parathyroid adenoma was found intraoperatively on the opposite side in one of these two patients which was due to the coexistence of a multinodular thyroid gland interfering with the scan interpretation ( Figure 2 ). Ten patients in our 
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Parathyroid scan interpretation study population were known to have coexisting multinodular thyroid gland, but this was the only patient with whom it interfered with the interpretation. The other patient with nonlocalizing SPS had an enlarged right submandibular gland which resulted in a false positive SPS, ultrasound, and 4D CT which resulted in removal of submandibular glandular tissue instead of the parathyroid adenoma (Figure 3) . The average intraoperative PTH measurements decreased below 50% of the preoperative measurement with average postoperative level 39.7 pg/mL, except in one patient where the adenoma was not found intraoperatively. Pathology confirmed the resection of the parathyroid adenoma in 52/53 patients (98%). The validation of accuracy of our interpretation method for localizing a parathyroid adenoma in relation to the trachea in 48 patients with perfect correlation is shown in Table 2 .
Discussion
Single isotope dual-phase parathyroid scan had a major impact on the ease, accuracy, and utility of parathyroid scan for presurgical evaluation of patients with PHPT. 17, 18 The addition of SPECT and SPECT/CT technology represents the second most important advancements of parathyroid scintigraphy which has significantly facilitated minimally invasive parathyroidectomy. [20] [21] [22] [23] 26 Multiple studies in the literature compare the performance of parathyroid scan to other anatomic imaging modalities. 10, 24, 25 Also in most institution, parathyroid scintigraphy is complemented with other anatomic imaging modalities; ultrasound, CT, and/or MRI for the localization of parathyroid adenomas. Our study aims to optimize the utility and interpretation of Tc-99m SPS with SPECT/CT for the diagnosis and localization of the abnormal parathyroid gland. Our results showed 90.6% accuracy of localization parathyroid adenoma site with a decrease in PTH level and pathologically confirmed parathyroidectomy. Although Quiros et al had lower accuracy results using SPS of 75% and 56% using ultrasound in a study included 71 patients, we both conclude that a positive SPS is the only preoperative required test in most patients with PHPT. 27 Prior literature by Perrier et al described an alphabetical nomenclature of the different possible positions of parathyroid adenoma in the neck and in relation to the thyroid gland. This nomenclature assigns letters "A" through "F" for different surgical possible locations of the parathyroid adenoma. 28 Perrier suggests that this alphabetical nomenclature system can facilitate communication between imagers and surgeons and can decrease ambiguity. Thus, it can easily guide the surgeon to the localization of the abnormal parathyroid intraoperatively. However, this nomenclature system can be used surgically, but it is difficult to apply to parathyroid scintigraphy because of the ballooning effects of radiotracer uptake in the abnormal parathyroid gland in addition to the limited resolution of gamma camera to structures <1 cm, which makes the nomenclature inapplicable in many instances when interpreting SPS and difficult to use to describe the exact location of a parathyroid adenoma. Particularly, it is difficult to differentiate type A from B adenomas, and C from D or E adenomas on SPS. In our study, we describe a more relevant and simple method of identifying and localizing the abnormal parathyroid adenoma in relation to the trachea in a clockwise fashion and in relation to the thyroid in a cranio-caudal level. Our interpretation method facilitates the reporting and communication between the imager and the surgeon, which translates into easier and faster localization of the abnormal gland intraoperatively with less invasive procedure and smaller operative scar. The abnormal parathyroid adenoma may also be localized with a clockwise numbering system around the trachea in a similar fashion to breast abnormalities when reported on ultrasound or mammogram. Thus, a right inferior parathyroid adenoma is usually located at the right anterolateral position relative to the trachea at 10 o'clock position, the left inferior parathyroid adenoma is located at the left anterolateral position at 2 o'clock relative to the trachea, the left superior is located at the left posterolateral position relative to the trachea at 5 o'clock, and the right superior is located in the right posterolateral position relative to the trachea at 7 o'clock ( Figure 1 ). In addition, the level of the parathyroid adenoma level would be described in relation to the thyroid lobes in a cranio-caudal level. Our proposed interpretation methods identify the abnormal inferior versus superior parathyroid adenoma by its depth in relation to the trachea rather than by its position in relation to the thyroid, since many superior parathyroid adenomas tend to grow inferiorly behind the thyroid gland in the trachea-esophageal groove. 29 Our results support the robustness and high accuracy of our method of interpretation and localization with 90.6% accuracy in identifying the exact location of the abnormal parathyroid gland correctly and 96.3% accuracy in identifying the laterality of the involved parathyroid gland. Our results also confirm superior results from a large meta-analysis study performed by Treglia et al which included pooled data from 23 studies for 1236 patient with Tc-99m MIBI SPECT/CT detection rate of 88% both on a per patient and per lesion analysis. 30 A limitation of our study is the fact that it is a retrospective study, and not all patients who underwent parathyroid scans also underwent operative resection. Most likely, surgical management was not indicated in these patients. It is unlikely that it was due to nonlocalization or indeterminate parathyroid scan, since all patients without surgical management had a localizing parathyroid scan reports.
Although 10 patients in our study population were known to have multinodular thyroid gland, only one patient had a nonlocalizing SPS due to the interference with thyroid nodules. This is probably one of the strength of using SPECT/ CT as an integral part of SPS with better localization of focal abnormalities to the thyroid or outside the thyroid.
Our technique for localizing the abnormal parathyroid gland may be achieved in CT and MRI interpretation for parathyroid adenomas, although not tested in this study. However, the similarities between SPECT/CT, CT, and MRI in the tomographic nature of imaging would suggest the usefulness of our interpretation method if applied to the other tomographic imaging modalities.
Conclusion
Our study demonstrates high accuracy of Tc-99m sestamibi dual-phase scan with SPECT/CT in identifying the location of an abnormal parathyroid scan in PHPT using our systematic optimized interpretation method. Our optimized interpretation methods localize the parathyroid adenoma relative to the trachea and thyroid. A clockwise numerical position around the trachea can further simplify accurate localization of the parathyroid adenoma and facilitates communication between the imagers and the surgeons. Our results support the possible use of SPS as the sole diagnostic modality in most patients with primary PHPT with good surgical results. 
